Semglee and Insulin Glargine may now be substituted for the reference product Lantus (insulin glargine) at the pharmacy counter. Viatris Inc. and Biocon Biologics have announced the launch of ...
Credit: Getty Images. Rezvoglar may now be substituted for Lantus at the pharmacy counter without the need for an intervention from the prescriber. The Food and Drug Administration (FDA) has approved ...
On November 18th, the U.S. Food and Drug Administration (FDA) announced its approval of Eli Lilly's Rezvoglar (insulin glargine-aglr) product as an interchangeable biosimilar to Sanofi's Lantus ...
Mylan sought approval for generic version of Sanofi's SoloStar Generic maker won on challenges to several Sanofi patents Court rejects Sanofi's appeal of decisions (Reuters) - A U.S. appeals court on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback